Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake

被引:1
作者
Dowling-McClay, Karilynn [1 ]
Mathis, Stephanie M. [2 ]
Hagemeier, Nicholas [1 ]
机构
[1] East Tennessee State Univ, Bill Gatton Coll Pharm, Box 70657, Johnson City, TN 37614 USA
[2] East Tennessee State Univ, Coll Publ Hlth, Box 70623, Johnson City, TN 37614 USA
来源
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY | 2021年 / 4卷
关键词
HIV; Hepatitis C; Nonprescription syringe; Community pharmacy; Pharmacist; Prevention; NONPRESCRIPTION SYRINGE SALES; INJECTION-DRUG USE; HEPATITIS-C; UNITED-STATES; WEST-VIRGINIA; PEOPLE; CARE; PROGRAMS; INTERVENTIONS; MANAGEMENT;
D O I
10.1016/j.rcsop.2021.100088
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The central Appalachian region is at an elevated risk for HIV/HCV outbreaks, primarily due to injection drug use. Regional risk assessments highlight gaps in the evidence-based continuum of primary, secondary, and tertiary prevention strategies to minimize HIV/HCV transmission. One potential strategy for increasing the reach of HIV/HCV prevention efforts in rural areas is through provision of services at community pharmacies.Objective: To qualitatively describe community pharmacists' HIV/HCV-related prevention behaviors, attitudes, and beliefs ina 3-state central Appalachian region.Methods: Key informant interviews were conducted with 15 practicing community pharmacists. Theory of Planned Behavior-based questions probed for perceptions about the role of pharmacies in preventing and reducing HIV/HCV outbreaks in rural areas through activities such as syringe services, screening for HIV/HCV, and linking people to treatment when appropriate. Investigators applied thematic analysis to deductively and inductively generate themes from the interview transcripts.Results: Two overarching themes regarding pharmacist engagement in HIV/HCV-related prevention services were generated: 1) current approaches to primary prevention through nonprescription syringe sales (e.g., gatekeeping behaviors) and 2) potential for uptake of the continuum of HIV/HCV-related prevention services in community pharmacies. Future engagement of community pharmacists in the continuum of HIV/HCV-related prevention services comprised 2 subthemes as possible underlying factors: general and specific willingness to provide services and perceived fit within the pharmacy profession.Conclusions: Central Appalachian community pharmacists express a general willingness to help patients who may benefit from HIV/HCV-related prevention services, but current engagement, willingness, and perceived fit for offering specific prevention services in the community pharmacy setting is variable. This has potential immediate implications, such as prioritizing the introduction of more widely accepted services (e.g., provision of HIV/HCV-related prevention education) to community pharmacy practice, and longer-term implications, such as the integration and framing of HIV/HCV-related prevention services as helping behavior within the pharmacist professional identity.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings
    Min, Amy C.
    Andres, Jennifer L.
    Grover, Anisha B.
    Megherea, Oxana
    HEALTH PROMOTION PRACTICE, 2020, 21 (05) : 831 - 837
  • [2] Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US
    Des Jarlais, D. C.
    Cooper, H. L. F.
    Arasteh, K.
    Feelemyer, J.
    McKnight, C.
    Ross, Z.
    PLOS ONE, 2018, 13 (03):
  • [3] Community Engagement and Investment in Biomedical HIV Prevention Research for Youth: Rationale, Challenges, and Approaches
    Ellen, Jonathan M.
    Wallace, Melissa
    Sawe, Fredrick K.
    Fisher, Kevin
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 : S7 - S11
  • [4] Current and (Potential) Future Effects of the Affordable Care Act on HIV Prevention
    Viall, Abigail H.
    McCray, Eugene
    Mermin, Jonathan
    Wortley, Pascale
    CURRENT HIV/AIDS REPORTS, 2016, 13 (02) : 95 - 106
  • [5] Community engagement tools in HIV/STI prevention research
    Li, Chunyan
    Zhao, Peipei
    Tan, Rayner K. J.
    Wu, Dan
    CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (01) : 53 - 62
  • [6] Management practices in community-based HIV prevention organizations in Nigeria
    Akeju, David
    Nance, Nerissa
    Salas-Ortiz, Andrea
    Fakunmoju, Ayoola
    Ezirim, Idoteyin
    Oluwayinka, Adejumoke G.
    Godpower, Omoregie
    Bautista-Arredondo, Sergio
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [7] Current Practices of Screening for Incident Hepatitis C Virus (HCV) Infection Among HIV-Infected, HCV-Uninfected Individuals in Primary Care
    Freiman, J. Morgan
    Huang, Wei
    White, Laura F.
    Geng, Elvin H.
    Hurt, Christopher B.
    Taylor, Lynn E.
    Overton, E. Turner
    Cachay, Edward R.
    Kitahata, Mari M.
    Moore, Richard D.
    Rodriguez, Benigno
    Mayer, Kenneth H.
    Linas, Benjamin P.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1686 - 1693
  • [8] Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP)
    Meyerson, B. E.
    Dinh, P. C., Jr.
    Agley, J. D.
    Hill, B. J.
    Motley, D. N.
    Carter, G. A.
    Jayawardene, W.
    Ryder, P. T.
    AIDS AND BEHAVIOR, 2019, 23 (07) : 1925 - 1938
  • [9] Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis
    Salwan, Aaron
    Hagemeier, Nicholas E.
    Tudiver, Fred
    Dowling-McClay, Karilynn
    Foster, Kelly N.
    Arnold, Jessie
    Alamian, Arsham
    Pack, Robert P.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (06) : E173 - E178
  • [10] A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian
    Watson, L
    Bond, C
    Gault, C
    JOURNAL OF PUBLIC HEALTH MEDICINE, 2003, 25 (01): : 13 - 18